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|sjutritional Implications of Liver Transplantation 
Jeanette M. Hasse, MS, RD, LD, CNSD' 
Malnutrition is a common problem of patients undergoing liver transplantation. To treat malnutri-
tion, it must first he identified through a nutritional assessment. Because many objective nutrittonal 
assessment parameters have limitations in end-stage liver disease, subjective nutritional indicators 
may be used as an alternative. Nutritional needs following transplantation are categorized as short 
and long term. The short-term nutritional goal, anabolism, can be complicated by the nutritional 
status ofthe patient, surgical procedures, and necessary medications. The increased nutrient needs 
during the early posttransplant phase require particular nutritional support. Nutrition-related 
problems following transplantation may include obesity, hyperlipidemia. hypertension, diabetes 
mellitus. hyperkalemia, edema, or osteoporosis. Dietetic advice relative to the nutritional needs ofthe 
liver transplant recipient can improve hoth the short- and long-term outcomes. (Henry Ford Hosp 
MedJ 1990:38:235-40) 
L iver transplantation has becorae a therapeutic option for hundreds of victiras of hepatic failure each year (1-3). Ira-
proved survival rates of liver transplant recipients in the past 
decade are due to many factors including iraproved surgical 
techniques and raethods of organ preservation, better selection 
criteria for recipients, advances in understanding ofthe immune 
.system, introduction of new imraunosuppressive agents, and in-
creased knowledge in the prevention and raanageraent of poten-
tially fatal coraplications (1,4-8). 
Debility, raalnutrition, encephalopathy, and raassive ascites, 
conditions associated with end-stage liver disease (ESLD), con-
tinue to be risk factors in transplantation (1). Accordingly, treat-
ment ofthese condirions, which is largely dependent on proper 
attention to nutrition, iraproves the probability of successful 
transplantation (7,9-12). 
they 
Nutritional Assessment of the 
Liver Transplant Candidate 
In order to treat nutritional abnorraalities and malnutrition, 
t e  must first be identified. The task of the dietitian working 
with liver transplant patients is to coraplete the nutritional as-
sessment which, at Baylor University Medical Center (BUMC), 
occurs during the initial evaluation of a patient's suitability for 
liver transplant. Deterraining the nutritional status of a pretrans-
P'ant patient raay be hampered by the effect of the liver disease 
on the usual pararaeters of objecrive nutritional assessment. 
These include body weight, anthropometric measureraents, uri-
nary creatinine and 3-raethylhistidine excretion, nitrogen bai-
lee, serura visceral protein levels, tests of delayed hypersensi-
'•vity, and the total lymphocyte count (TLC) (9,10,13-16). 
Objective nutritional assessment parameters 
The most coramonly used nutritional assessraent pararaeter i*^  
bod ly weight. However, weight measureraent raay not be a valid B 
nutritional index in patients with ESLD because ederaa, ascites, 
and adrainistration of diuretics alter body weight (9,10,13). Loss 
of lean body raass in a pretransplant patient raay be masked by 
concurrent fluid retention when body weight is used as the nutri-
tional indicator. 
Anthropometric measureraents (tricep skinfold and arra mus-
cle circumference) have been proposed as more accurate than 
body weight as markers of nutritional status in pretransplant pa-
tients (10,15). However, there are raulriple sources of error in 
this procedure, including observer errors, instruraent errors, tis-
sue corapartment changes, and inaccurate applicarion of the 
raeasureraents (17). Another problem is that the raass of intemal 
fat raay not always be proportional to that found in skinfolds, 
and changes in total body water raay have an effect on skinfold 
raeasureraents (18). Because available standards for anthro-
poraetric raeasurements do not account for variations in hydra-
tion and skin compressibility, they raay not be valid for use in 
studies of comparisons of measureraents for patients with ESLD 
(9,13). Anthropometric raeasureraents are best used for assess-
raent of ESLD patients in long-term monitoring, with measure-
raents made by the same observer. They are not reliable as an in-
itial nutritional assessraent index (9,13). 
Creatinine-height index (CHI), another nutritional assess-
ment parameter, is used to raeasure static protein reserves but 
raay not be practical for evaluation of candidates for liver trans-
plant. Malnutrition, aging, decreased body raass, and subopti-
raal protein intake all can be altered in ESLD and will affect CHI 
values (13,16). The hepatorenal syndrorae occurs with sorae 
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frequency in the pretransplant population and also alters CHI 
(13,14). The required 24-hour urine speciraens are difficult to 
collect. In addition, levels of creatinine, a raetabolite of creatine 
which is synthesized in the liver (19), are likely to be abnorraal 
and cause an erroneous CHI raeasureraent. 
Nitrogen balance studies, like CHI studies, require 24-hour 
urine collections as well as concurrent records of protein intake. 
Both are difficult to obtain unless subjects are raaintained in a 
controlled environment. The hepatorenal syndrome, which is 
fairly comraon in patients with ESLD, leads to nitrogen reten-
tion in the forras of BUN and aramonia. Consequently, nitrogen 
excretion is decreased, making a true nitrogen balance study un-
realistic (9,13,20). 
Three-methylhistidine in urine is a biochemical marker used 
to estiraate protein stores. Mean 3-raethylhistidine values were 
norraal in a study of 74 pre-liver transplant patients, although re-
duced muscle raass affected the levels (16). Renal function, age, 
sex, dietary intake, trauraa, and infection also affect 3-raeth-
ylhistidine excretion (21). 
Protein status is often estiraated frora measurements of serura 
levels of alburain, transferrin, prealburain, and retinol-binding 
protein whose levels are coraraonly depressed in liver failure 
(9,10,13,15,16,22). Levels of these serum proteins are affected 
by the state of hydration, hepatic necrosis, renal insufficiency, 
malabsorption, zinc deficiency, iron stores, or cortisone adraini-
stration (9,10,13). In ESLD, serura protein levels are not reliable 
pararaeters for nutritional assessraent (9,10,13,15,16,20). 
Iraraune function, often measured by skin antigen testing or 
TLC, is used often as a nutritional indicator (21). Not only does 
a depressed nutritional state irapair host defense, but in the pres-
ence of severe hepatic dysfunction inhibitory factors have been 
identified which depress iraraune function (10). Skin antigen 
testing and delayed hypersensitivity reaction are affected by 
hepatic failure, electrolyte imbalance, infection, renal insuffi-
ciency, immunosuppressive raedications, and raetabolic stress 
(13). Iramune function indicators are avoided as nutritional pa-
rameters in patients with ESLD because they are considered to 
be imraunosuppressed (13). 
Because these nutritional pararaeters are frequently altered by 
variables other than nutrition (9,10,13-16,20), other indicators 
have been suggested to determine the nutrirional status ofthese 
parients. Clinical judgment must take into consideration diet 
history and physical findings, as well as biochemical raeasure-
ments (9,13,16). 
Subjective nutritional assessment parameters 
A "subjective" approach is used at BUMC to assess the nutri-
tional state of liver transplant recipients. The technique was 
adapted frora the original "subjective global assessraent" (SGA) 
by Detsky et al (23) and focuses on information obtained frora 
the patient as well as the dietitian's observations. The patient is 
questioned about weight change (loss and/or gain of lean raass, 
fat raass, or fluid accuraulation), nutritional intake, gastrointes-
tinal syraptoras, physical capacity, and presence and duration of 
other conditions that affect nutritional state. The information is 
ranked into degrees of severity. For example, if the patient is 
questioned about vomiting, the response is categorized as no 
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vomiting, vomiting for less than one week, or vomiting f^^^ 
least one week. The observer assesses the degree of the patient 
fat and rauscle depletion and degree of ascites or edema. Patients 
are ranked as well nourished, raoderately (or suspected of being) 
malnourished, or severely raalnourished (according to the origj 
nai SGA). Although this approach is dependent upon both pj 
tient recall and the rater's skill, it has been found to be valid jj 
surgical patients (23,24) and judged to be useful in liver trans, 
plant candidates (25). In a study of 20 patients at BUMC, thj 
raethod was found to have fair to good interrater reliability (25) 
Prevalence of Malnutrition in 
Liver Transplant Candidates 
Malnutrition is coramon in ESLD patients (1,9,13,15,16,22), 
Nutritional assessment of BUMC liver transplant candidates con-
firms these reports. Of 435 transplant candidates, 128 (29.4%) 
were well nourished, 244 (56.1%) raoderately (or suspected of 
being) malnourished, and 63 (14.5%) severely malnourished. 
The prevalence of malnutrition in liver transplant recipients 
underscores the need for appropriate nutritional care before and 
after fiver transplantarion (9,10,13,22,26). These nutritional 
needs can be described as short- and long-term requirements. 
Variables Affecting Short-term 
Posttransplant Nutritional Goals 
The short-term posttransplant nutritional goal is anabolism. 
Specific needs of the recipients are dependent on variables sucli 
as present nutritional state, surgical procedures perforraed at the 
tirae of transplant, effects of postoperative medications, and any 
associated medical coraplications. 
In a study of 74 liver transplant candidates, nutritional status 
was found to vary with the type of liver disease (16). Ascites 
was prevalent in patients with chronic active hepatitis, and ca-
loric stores were often depleted while protein stores remained 
within normal liraits. Patients with sclerosing cholangitis often 
displayed only muscle wasting, while victiras with priraary bil-
iary cirrhosis displayed marked fat and muscle wasting althougli 
they retained good synthesis functions ofthe liver. Patients witn 
any fulminant disease were stressed and acutely depleted. Indi' 
vidual goals are dependent on the nutritional state which is 
fluenced by the nature of the primary liver disease. 
Another factor in individual nutritional care plans is the type 
of transplant surgery. A choledochojejunostoray requires more 
sraall bowel raanipulation than does a choledochocholedochoS' 
tomy and raay delay initiation of oral intake. A new transpl^ "' 
procedure called a "cluster" transplant has raany nutrition 
raraifications. This procedure is indicated for raalignancies i 
volving not only the liver but also the pancreas, duodenum, 
colon. The liver is reraoved with the patient's pancreas, duo 
nura, spleen, proxiraal jejunura, storaach, and raost ofthe coio"' 
Organ cluster grafts of liver, pancreas, and duodenum are 
placed (27). Since raany digestive organs are reraoved, there' ^ 
high potential for raalabsorption, duraping syndrome, and g 
cose intolerance. ,^  
The third nutrition-influencing factor, medication, is ^ " ^ ^ " - i 
able because imraunosuppressive dmgs are essential to pre i 
Nutritional Needs in Liver Transplantatio"' 
Table I 
Side Effects of Immunosuppressive Medications Used in 
Liver Transplantation 
Iniff 
unosuppressiveDrug Side Effeci 
Cyclosporin'^  
Glucocorticoids 
Its. 
Azathioprine 
0KT3 
Nephrotoxicity (8.29.30-32) 
Hepatotoxicity (30-32) 
Hypertension (8.29,33) 
Hyperlipidemia (31,34) 
Hyperkalemia (28,31,33) 
Magnesium wasting (8,31) 
Hyperglycemia (20.31.35) 
Gingival hypertrophy (31,36) 
Hirsutism (31) 
Tremor (31.33) 
Paresthesias (31,33) 
Headache (33) 
Catabolism and impaired wound 
healing (30,31) 
Hyperglycemia (30,31,33.37) 
Hyperlipidemia (31) 
Sodium retention (30,31) 
Electrolyte disturbances (30.31.33) 
Increased appetite (31) 
Increased calcuria (31,33) 
Developmeni of peptic ulcers (31) 
lncrea.sed hair growlh (31) 
Acne(31) 
Mood swings (31) 
Nighl sweats (31) 
Bruising of the skin (31) 
Blurred vision (31) 
Moon face (31) 
Joinl pain (31) 
Insomnia (31) 
Increased sun sensitivity (31) 
Developmeni of cataracts (31) 
Nausea (31) 
Vomiting (31) 
Sore throat (31) 
Altered taste acuity (31) 
Macrocytic anemia (31) 
Nausea (30,31) 
Vomiting (30,31) 
Diarrhea (30,31) 
Loss of appetite (31) 
Fever and chills (30.31) 
organ rejection. These raedications include cyclosporine A 
(CYA), steroids, azathioprine, and 0KT3 and have many nutri-
tional side effects (8,20,28-37) (Table I). New immunosuppres-
sive drugs currently under investigation include FK-506, RS-
61443, and rapamycin. Other comraonly used posttransplant 
medications such as antacids, antibiotics, and diuretics can pre-
cipitate diarrhea, constipation, irapaction, nausea, voraiting, an-
orexia, polydipsia, and electrolyte irabalance (4,30,31,33). 
Postoperative complications which affect decisions about nu-
trition include organ rejection, infection, acute renal failure, bil-
'*ry, intestinal, and pulmonary coraplications, hypotherraia, 
*ound complications, and pancreatitis (2,4,6,29,32). 
These various medical conditions affect nutrition. For exam-
ple, ifa transplanted graft fails to function, another eraergency 
fransplant may be required (32). During the time from the initial 
'0 the subsequent liver transplant, nutrition support is compli-
cated by the inability of the nonfunctioning graft to metabolize 
nutrients. Acute rejection of a transplanted liver often requires 
additional steroid administrarion which amplifies the side ef-
fects of these drugs. Chronic rejection may result in such severe 
hepatic damage as to require reinstatement of nutritional princi-
ples for ESLD. 
Transplant recipients are at high risk not only for rejection but 
also for infection. The high rate of infection in posttransplant pa-
tients may be affected by immunosuppression, the use of anti-
biotics, preoperative malnutririon, and/or antacids that perrait 
bacterial overgrowth in the stomach (32). In the presence of 
widespread infection or sepsis, nutritional needs are increased 
and antibiotic therapy raay be initiated. Not only do the infec-
tion and fever affect appetite, but the antibiotics may produce 
diarrhea, taste changes, and anorexia (31). 
Renal function also affects nutritional needs. CYA raay be 
nephrotoxic and renal irapairraent occurs with sorae frequency 
following liver transplant (6,32). Alterations in electrolyte ther-
apy, a decrease in protein intake, and restriction of fluid intake to 
raatch output raay be indicated. 
Coraplications of other organ systeras such as pulraonary, 
biliary, or intestinal tracts can require changes in types and 
amounts of nutrients, but, more frequentiy, require a change in 
the nutritional route. For example, ventilator support with intu-
bation or occurrence of sraall bowel obstruction requires nutri-
tion by other than oral raeans. 
Hypotherraia is another reported postoperarive complication 
of liver transplantation (6,20,32). The response to hypothermia 
is shivering, vasoconstricrion, hyperventilation, and alkalemia, 
with increased cardiac output and oxygen consumption (6). In-
creased oxygen consuraption and shivering increase the patient's 
energy expenditure. 
Wound complications also have nutrirional effects. The pres-
ence of a large open wound or raany drain sites requires addi-
tional nutrition to corapensate for nutrient losses. 
Pancreatitis occurs infrequentiy (4). Mild pancreatitis raay 
only delay the onset of oral intake, but more severe attacks re-
quire bowel rest and total parenteral nutrition (TPN). 
Short-term Posttransplant 
Nutrient Requirements 
Nutrient needs are increased imraediately posttransplanta-
tion. In one study of eight patients, mean resting energy expen-
diture (REE) rose 36% to 38% above the predicted resting en-
ergy expenditure (FREE) (based on the Harris-Benedict equa-
tion) on the first and second days after surgery (38). In another 
study, measured REE was only 7% higher than FREE (27), but 
FREE raay have been overestimated by calculations eraploying 
the patient's actual weight (including ascites) rather than dry 
weight. When indirect calorimetry equipment is not available to 
raeasure individual postoperative needs, caloric requireraents for 
transplant patients may be estiraated at about 1.5 tiraes the basal 
energy expenditure (BEE) using the Harris-Benedict equation. 
A range of 140% to 170% of BEE is suggested, or 33 to 40 kcal 
per kg of ideal body weight (20). At BUMC, the patient's lowest 
recent weight is used to estiraate dry body weight for calculating 
energy and protein needs. 
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Table 2 
Short- and Long-term Nutritional Needs of the Adult Liver Transplant Patient 
Nutrient Short-term Needs IjOng-lerm Needs 
Calories 1.4-1.7 X BEE (20.39) For weight mainlenance 
aboul 1,2 X BEE (39) 
Protein 1.5-2.0 g/kg (20.30.34) 0,8-1,0 g/kg (39) 
Carbohydrate 50%-70% of nonprotein calories. No added sugar, low 
decrease if glucose is concentrated carbohydrate 
elevated (30.39) (20,30,39) 
Fat 30%-50% of nonprotein calories, < 30% of calories as fat. 
decrease if triglycerides are < 10% of calories as 
elevated (39) saturated fal (39) 
Fluid Restrict fluid as needed for 
edema/ascites (30,39) 
Sodium Restrict to 2-4 g as needed 
for edema/ascites (30,31,39) 
4 g (30,31,39) 
Potassium Supplementation/restriction 
depends on serum potassium 
level 
Same as short-term plan 
Magnesium Supplemenl when low wiih 1 Encourage inlake of high magnesium-
Slo-Mag tablet three containing foods, supplemenl according 
times a day 10 short-term plan 
Phosphorus Supplement when low with 2 Encourage intake of high phosphorus-
Neulra-Phos capsules three containing foods, supplemenl 
limes a day according lo short-lerm plan 
Calcium Supplement when low or in Encourage inlake of high calcium-
females near menopausal age containing foods, supplement 
or in olher patients with according lo short-term plan 
hislory of bone deterioration* 
* Women: Two Florical capsules three limes a day, one 0.25 |ig calcitriol capsule per day, 0.1 mg estradiol patch changed every 
3 days and worn three out of four weeks. Men: exclude estradiol patch. 
The hyperraetabolic postoperative transplant patient is in a 
catabolic state. In a study of eight posttransplant patients, raean 
nitrogen excretion (urinary urea nitrogen [UUN|)was found to 
be 20.1 g on the first postoperative day and 24.6 g on the second 
postoperative day (38). In another study, UUN excretion was 
less than the previous study (12.9 ± 4.4 g/day), but it was raea-
sured on the third postoperative day (27). The large nitrogen 
losses are due to steroid therapy, rauscle catabolisra in an unfed 
state, and stress from surgery (27,30). A protein load of 1.3 to 2 
g/kg of dry body weight is recoraraended (20,30). The BUMC 
care plan calls for 1.5 g/kg. 
Other nutritional changes after transplant must also be raoni-
tored (39). Carbohydrate and fat are not restricted in the imme-
diate postoperative period unless serura glucose and triglyceride 
concentrations indicate intolerance. Sodium and fluid intake may 
be restricted if a patient retains excess fluid (30). Attention to 
electrolyte and mineral levels is mandatory. CYA can cause re-
tention of potassium while sorae diuretics waste potassiura (Ta-
ble I). Accelerated loss of raagnesiura has been associated with 
both CYA (40,41) and diuretic therapy. Depleted semm magne-
sium levels may lead to tetany or seizures (8,31,40-42). Phos-
phorus and calcium may also require supplementation (Table 2). 
Nutrition Support Following 
Liver Transplantation 
The urgent need for increased nutrients imraediately post-
transplant may require special nutritional techniques. TPN is ad-
rainistered to all liver transplant patients at some centers but is 
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not used routinely at many others (20,30). At BUMC, TPN or 
tube feeding (TF) is administered only to patients with one ot 
more complications—severe raalnutrition, prolonged ileus or 
ventilator dependence, persistent voraiting or diarrhea, inability 
to eat adequately, or altered neurologic status affecting eating 
(39). In 427 transplant patients at BUMC, 140 (32.7%) received; 
some type of nutrition support; 38 (8.9%) received TF alone, 51 
(11.9%) received TPN alone, and 51 (11.9%) received a combi-
nation of parenteral and enteral nutrition. 
Nutrition support is used only as an altemative to oral diets. 
When ileus resolves usually three to four days postoperatively, 
the patient is advanced to an unrestricted general diet (32,39) 
However, poor appetite, altered taste, and early satiety often 
haraper the patient's ability to eat adequately (30). Freque"' 
feedings, oral suppleraents, and additional raenu choices en-
hance the opportunity to achieve nutrirional goals. The ade-
quacy of intake is monitored via calorie counts, and intake is 
compared to the patient's esrimated needs (39). 
If a patient has a functioning gastrointestinal tract but is unabl^  
to consume an adequate diet or is at high risk for aspiration, a snia> 
bowel feeding tube is placed (9,30,32,39). Difficulties whi'* 
can develop frora TF include diarrhea, volume overioad. depf^ '^  
sion of appetite, and restriction of physical mobility. Diarthe^ 
frequently reported complication, can have raany etiologies Med-
ications are comraon culprits. Magnesiura-containing antae 
can be changed to alurainum-containing antacids. Althou, 
tibiotics may cause diarrhea, their use cannot always be avoi" 
Fiber-enriched TF formulas have been helpful in preventing 
arrhea, and antidiarrheal raedications raay be required. 
aha"' 
Nutritional Needs in Liver Transplantation' 
Volume restriction, necessary in a posttransplant patient who 
(jevelopmS ^'^''^ overload, can be achieved through the use of 
entrated forraulas, 1.5 and 2 kcal per raL. 
'^ '^ physieal mobility can be hampered by the tube feeding equip-
but noctumal feedings can allay this problem. Noctumal 
feedings are favored when possible because the patient has raore 
..ctricted ambularion and a better appetite during the waking i^rirestii 
hours (9)-
[fa patient cannot tolerate a tube feeding or if enteral feedings 
contraindicated by a nonfunctioning gastrointestinal tract 
32), high risk of aspiration (9), sraall bowel obstruction, pan-
creatitis (4)^  or gastrointestinal fistulas, TPN is the nutritional 
route of choice. Difficulties encountered with the initiation of 
jpN include fluid overload, intolerance to nutrient substrates, 
cholestasis, and electrolyte disturbances. When volume restric-
tion is necessary, a concentrated nutrient forraula can be infused 
via a line placed in a central vein. Patients may not tolerate large 
amounts of intravenous protein, gluco.se, or lipids. Tolerance is 
monitored by serum BUN, glucose, and triglyceride levels, and, 
if any rise dramatically, the amount of the corresponding nutri-
entmay be reduced. If hyperglycemia occurs, sliding-scale insu-
lin may be given and insulin can be added to the TPN solution. 
Standard amino acid solutions are provided to most posttrans-
plant patients while high branched-chain araino acid forraulas 
are reserved for encephalopathic patients. 
Liver biopsy following liver transplantation reveals cholesta-
sis in sorae cases. Cholestasis raay be secondary to ischeraic in-
sult to the donor organ but raay be exacerbated by excessive cal-
ories administered by TPN (27). Care not to overfeed patients 
minimizes the potential for TPN-induced cholestasis (27). 
Electrolyte disturbances which may also occur with TPN can 
be avoided by daily raonitoring of laboratory values and adjust-
ing TPN forraulations. 
Although TF or TPN may be required in the short-term post-
transplant phase, the nutritional goal is anabolism, with an oral 
diet as the route of choice. 
Long-term Posttransplant 
Nutritional Complications 
Nutritional goals in the long-terra post liver transplant phase 
are different frora those during the short-terra phase. Whereas 
the short-terra goal is anabolism, long-term goals are raainte-
nance and prevention. Nutrition-related probleras which may 
occur in the long terra after liver transplantation include exces-
sive weight gain, hyperlipidemia, hypertension, diabetes, hy-
perkalemia, ederaa, and osteoporosis (20,29,30,43-45). 
Posttransplant obesity occurs in nearly 40% of BUMC pa-
tients one year after liver transplant. In a study of 46 such pa-
tients at the Mayo Clinic, median long-terra weight gain was 6.5 
1'g (29). This weight gain is due to an increased apperite, good 
liver function, steroid therapy, and an attitude of no restraint on 
eating patterns (30). 
The hyperlipidemia which is well documented in renal trans-
plant recipients (37,46) seems to respond soraewhat to a low fat, 
low cholesterol diet (37). Steroids and CYA have been irapli-
'^ ated as possible inifiators of the hyperlipidemia (34,36). Fur-
ther research is needed into the occurrence and manageraent of 
hyperlipidemia in liver transplant recipients. 
Hypertension occurs in 50% to 70% of posttransplant patients 
(29,43,44). Antihypertensive drugs are often needed and mildly 
restricted sodiura diets are encouraged (20,30). 
New onset diabetes meOitus can also occur following a liver 
transplant (29). This raay be due to steroid administration, but 
recent studies implicate CYA as a diabetes-inducing agent (35, 
45). Since the availability of CYA as a potent immunosuppres-
sive drug, steroid dosages have been reduced witb little differ-
ence seen in the occurrence of diabetes mellitus (45). Studies 
with rats suggest that glucose intolerance is a consequence of 
CYA use, due to the simultaneous development of insulin resis-
tance and inhibition of insulin secretion by beta cells (35). 
Three long-terra nutritional complications are linked to medi-
cations. Hyperkalemia, edema, and osteoporosis result in part 
from the use of iraraunosuppressive drugs. Hyperkaleraia oc-
curs with CYA (31). Ederaa can be induced by both steroids and 
CYA (31) while osteoporosis is a well-known consequence of 
steroid adrainistration (31). 
Long-term Posttransplant 
Nutrient Requirements 
Just as the nutritional goals and probleras in the short term 
differ from those in the long term, so do the nutritional needs of 
the liver transplant recipient also change. Calorie, protein, fat, 
carbohydrate, sodium, potassiura, calcium, caffeine, alcohol, 
and suppleraent needs are addressed by the dietitian for each 
transplant patient (39). 
In the long terra, caloric requirements dirainish to about 
120% of the BEE for weight raaintenance and protein needs de-
crease to approxiraately 0.8 to 1.0 g of protein per kg of body 
weight. To reduce hyperiipideraia, fat intake is limited to less 
than 30% of calories with restriction of saturated fat (20,30,39). 
Siraple carbohydrate products should be eaten only occasion-
ally and diabetic diets are instituted when diabetes occurs (20, 
30,39). Sodiura intake should not exceed 3 to 4 g datiy to help 
control blood pressure and fluid retention (20,30,39). If semra 
potassium remains elevated, dietary restriction is indicated. Cal-
cium must be adequate to compensate for an increased urinary 
loss secondary to steroids (20,30,39). Intake of caffeine and al-
cohol is discouraged. Vitarain suppleraentation is not required 
in most cases, and dosages of any nutrient above 200% of the 
Recoraraended Dietary Allowance is discouraged (Table 2). 
Nutritional Counseling Following 
Liver Transplantation 
Counseling by the transplant dieritian is essential to help liver 
transplant recipients understand their changing nutrient needs. 
Counseling is conducted forboth inpatients and outpatients. In-
patient counseling consists of daily rounds with the transplant 
team and brief conversations with each patient about his/her cur-
rent nutritional status and goals. Prior to hospital discharge, the 
transplant dietitian forraally counsels the patient and family raera-
bers on attaining the interraediate and long-terra nutritional goals 
(39). Outparient counseling includes individual counseling for 
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specific nutrition problems and required classes for patients and 
their families on the prevention of nutritional problems. 
Conclusion 
The nutritional needs of the liver transplant patient are ever 
changing. Liver transplant parients frequently experience a 
broad spectrum of nutritional problems. Obesity can occur in the 
same patient who suffered frora raalnutrition at the rime of 
transplant a year earlier. Although many questions reraain, at-
tention to nutritional needs improves both the short- and long-
terra outcomes of the liver transplant recipient. 
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